Method for preparing iPSC (induced Pluripotent Stem Cell) by free plasmid vector screened by non-antibiotics
A non-antibiotic screening and plasmid carrier technology, applied in the biological field, can solve the problems of insufficient safety and complex preparation of reprogramming vectors, and achieve the effects of improving reprogramming efficiency, low mRNA yield, and improving efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0102] This example discloses the idea of constructing an episomal plasmid vector for non-antibiotic screening. The construction strategy is as follows: figure 1 shown. figure 1 The bacterial sequence part of the episomal plasmid screened by non-antibiotics contains the R6K replication origin and the RNA-OUT sucrose selection marker, and the eukaryotic expression part consists of a conventional promoter, target gene and SV40poly-A. SV40 poly-A is a simian vacuolar virus PolyA tailing signal; the target gene represents the nucleotide sequence of the inserted foreign gene. The R6K origin of replication is derived from the original R6K-gamma origin of replication, and the length is greatly reduced after transformation, which retains the core sequence required for replication, removes the upstream 77 dimer repressor binding site and the downstream 77 promoter . The plasmid at the R6K replication origin needs Rep protein, so that the non-antibiotic-selected episomal plasmid can...
Embodiment 2
[0118] This example first discloses a method for reprogramming blood cells to generate pluripotent stem cells with an episomal plasmid vector containing OriP / EBNA1 non-antibiotic selection, the flow chart is as follows image 3 shown, including the following steps:
[0119] S1. Primary isolation, culture and identification of erythroid progenitor monocytes
[0120] S11. Primary isolation and culture of erythrocyte progenitor monocytes
[0121] Collect a blood sample of at least 10 μl, transfer it to a lymphocyte separation tube, centrifuge, take the mononuclear cell layer, wash it twice with DPBS centrifugation, take a sample and count it, and take 3×10 cells according to the counting result. 6 Cells were inoculated into 6-well plates in 3 wells, and erythrocyte progenitor cell expansion medium 2ml / well was added, and placed at 37°C, 5% CO 2 cultured in an incubator. Add 2ml of fresh expansion medium to each well on the 4th and 8th day of expansion respectively.
[0122] T...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com